Home › Funds › Taproot Management LP › WST

Taproot Management LP position in WST

WEST PHARMACEUTICAL SVSC INC · Health Care

Taproot Management LP reported holding 43,673 shares of WST (WEST PHARMACEUTICAL SVSC INC) in its Q1 2026 13F filing — a position valued at US$10.9M, representing 2.07% of its reported portfolio and ranking #2 among its reported holdings. Taproot Management LP has disclosed WST holdings in 2 of the last 2 reported quarters, going back to Q4 2025.

Latest position (Q1 2026)43.67K sh
Reported value held$10.95M
Portfolio Weight2.07%
First reportedQ4 2025
Last changeReduce
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How Taproot Management LP's WST position evolved

Taproot Management LP first disclosed a stake in WST in Q4 2025 at 44,758 shares (US$12.3M). Across 2 filings, Taproot Management LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q1 2026) shows 43,673 shares valued at US$10.9M — a reduction of -1,085 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 44.76K $12.31M New
Q1 2026 43.67K $10.95M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About WST and 13F data

WST (WEST PHARMACEUTICAL SVSC INC) is a Health Care company. 35 other funds we track also report a position in WST — the largest reported positions include Artisan Partners Limited Partnership (US$865.8M), GENERATION INVESTMENT MANAGEMENT LLP (US$728.2M), BROWN ADVISORY INC (US$386.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding WST

All WST fund holders →

FAQ

How long has Taproot Management LP held WST?

Taproot Management LP has disclosed WST holdings in 2 of the last 2 reported quarters, going back to Q4 2025.

What is Taproot Management LP's current position in WST?

As of Q1 2026, Taproot Management LP holds 43.67K shares of WST (WEST PHARMACEUTICAL SVSC INC), valued at $10.95M, representing 2.07% of its reported portfolio and ranking #2.

Has Taproot Management LP been buying or selling WST?

In the latest 13F filing (Q1 2026), Taproot Management LP reduced its position in WST.

Which other funds hold WST?

Other major institutional holders of WST include Artisan Partners Limited Partnership, GENERATION INVESTMENT MANAGEMENT LLP, BROWN ADVISORY INC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.